[关键词]
[摘要]
局灶性脉络膜凹陷(FCE)是一种以脉络膜局部结构凹陷为特征的隐匿性临床征象,随着光学相干断层扫描(OCT)技术的广泛应用而被识别,其发病机制尚未完全明确,可能涉及先天发育异常或后天获得性因素(如炎症、肿瘤压迫)。研究表明,FCE可独立存在或继发于多种脉络膜视网膜疾病(如中心性浆液性脉络膜视网膜病变、脉络膜骨瘤、年龄相关性黄斑变性等)。在临床中也发现其与脉络膜新生血管(CNV)的发生可能存在关联,FCE伴发CNV潜在的关联机制有:(1)机械牵拉-缺氧-信号通路激活;(2)视网膜色素上皮(RPE)-Bruch膜-脉络膜复合体屏障破坏;(3)炎症瘢痕收缩诱导的结构塌陷,对伴发于FCE的CNV治疗多以抗血管内皮生长因子(anti-VEGF)为主。文章通过整合国内外相关文献,探索阐明FCE与CNV的可能病理关联,为早期识别高危患者、优化抗VEGF治疗提供依据,同时指出当前研究的局限性(如样本异质性、分型标准缺乏组织学验证),建议未来开展多中心研究及分子机制探索,以助力个体化诊疗方案的制定。
[Key word]
[Abstract]
Focal choroidal excavation(FCE)is an elusive clinical sign characterized by a localized structural depression in the choroid. It has been increasingly recognized with the widespread use of optical coherence tomography(OCT), though its pathogenesis remains incompletely understood and may involve congenital developmental anomalies or acquired factors(such as inflammation or tumor compression). Studies indicate that FCE can occur independently or secondary to various chorioretinal diseases(e.g., central serous chorioretinopathy, choroidal osteoma, age-related macular degeneration, etc.). Clinically, it has also been observed that FCE may be associated with the development of choroidal neovascularization(CNV). Potential mechanisms linking FCE and CNV include: 1)mechanical traction-hypoxia-signaling pathway activation; 2)disruption of the retinal pigment epithelium(RPE)-Bruch's membrane-choroid complex barrier; 3)structural collapse induced by inflammatory scar contraction. Anti-vascular endothelial growth factor(VEGF)therapy is currently the mainstay of treatment for CNV secondary to FCE. By reviewing relevant domestic and international literature, this paper seeks to elucidate the possible pathological relationship between FCE and CNV, with the goal of facilitating early identification of high-risk patients and optimizing anti-VEGF treatment strategies. It also highlights the limitations of current research(such as sample heterogeneity and lack of histological validation of typing criteria), and suggests future directions, such as multicenter studies and molecular mechanism investigations, to support the development of personalized diagnostic and therapeutic approaches.
[中图分类号]
[基金项目]
庆阳市科技计划项目(No.QY-STK-2024A-121)